Treatment Innovations

A New Frontier in Microsurgery: Tissium Launches COAPTIUM CONNECT Following €60M Capital Injection a-new-frontier-in-microsurgery-tissium-launches-coaptium-connect-following-e60m-capital-injection

a-new-frontier-in-microsurgery-tissium-launches-coaptium-connect-following-e60m-capital-injection

A New Frontier in Microsurgery: Tissium Launches COAPTIUM CONNECT Following €60M Capital Injection

Laily UPN June 24, 2026

In a transformative milestone for peripheral nerve surgery, the French medical technology firm Tissium has officially announced...

Labcorp Launches ColoSense: A New Frontier in Non-Invasive Colorectal Cancer Screening labcorp-launches-colosense-a-new-frontier-in-non-invasive-colorectal-cancer-screening

Labcorp Launches ColoSense: A New Frontier in Non-Invasive Colorectal Cancer Screening

Lina Hope June 24, 2026

The landscape of preventative oncology has undergone a significant transformation this month as Labcorp officially launched ColoSense,...

Revolutionizing Vascular Access: PorTal Access Secures FDA Clearance for FLEXI-PORT System revolutionizing-vascular-access-portal-access-secures-fda-clearance-for-flexi-port-system

Revolutionizing Vascular Access: PorTal Access Secures FDA Clearance for FLEXI-PORT System

Nila Kartika Wati June 23, 2026

In a significant advancement for oncology and long-term intravenous therapy, Miami-based medical device innovator PorTal Access has...

The Great Pivot: BioNTech’s High-Stakes Bet to Reclaim its Oncology Roots the-great-pivot-biontechs-high-stakes-bet-to-reclaim-its-oncology-roots

The Great Pivot: BioNTech’s High-Stakes Bet to Reclaim its Oncology Roots

Reynand Wu June 23, 2026

By Brian Buntz The trajectory of BioNTech serves as a definitive case study in the volatile nature...

Masimo Secures FDA Clearance for AI-Powered OIRD Detection to Enhance Hospital Patient Safety masimo-secures-fda-clearance-for-ai-powered-oird-detection-to-enhance-hospital-patient-safety

Masimo Secures FDA Clearance for AI-Powered OIRD Detection to Enhance Hospital Patient Safety

Rifan Muazin June 23, 2026

In a significant advancement for hospital-based patient monitoring, medical diagnostics leader Masimo has announced that it has...

The 340B Standoff: Eli Lilly’s Data Ultimatum Escalates Industry Conflict the-340b-standoff-eli-lillys-data-ultimatum-escalates-industry-conflict

The 340B Standoff: Eli Lilly’s Data Ultimatum Escalates Industry Conflict

Azzam Bilal Chamdy June 23, 2026

In a move that marks a significant escalation in the long-standing war over the federal 340B drug...

The Borderless Pharma Frontier: Architecting Intellectual Property in a Globalized R&D Ecosystem the-borderless-pharma-frontier-architecting-intellectual-property-in-a-globalized-rd-ecosystem

The Borderless Pharma Frontier: Architecting Intellectual Property in a Globalized R&D Ecosystem

Neng Nana June 23, 2026

In the contemporary pharmaceutical landscape, the journey of a drug candidate from bench to bedside is rarely...

From Episodes to a Lifetime: The Evolution of Women’s Health Marketing in the Age of AI from-episodes-to-a-lifetime-the-evolution-of-womens-health-marketing-in-the-age-of-ai

From Episodes to a Lifetime: The Evolution of Women’s Health Marketing in the Age of AI

Nana Wu June 23, 2026

By Jennifer M. Barrett, MSc Published June 22, 2026 For decades, the pharmaceutical and healthcare industries have...

FDA in Turmoil: Commissioner Marty Makary Resigns Amid Administrative Pressure and Policy Clashes fda-in-turmoil-commissioner-marty-makary-resigns-amid-administrative-pressure-and-policy-clashes

FDA in Turmoil: Commissioner Marty Makary Resigns Amid Administrative Pressure and Policy Clashes

Jia Lissa June 23, 2026

By Investigative Desk In a move that underscores the profound volatility currently gripping the federal health apparatus,...

Early Intervention Critical: New Data Highlights Benefits of Rapid Thrombectomy in Intermediate-Risk Pulmonary Embolism early-intervention-critical-new-data-highlights-benefits-of-rapid-thrombectomy-in-intermediate-risk-pulmonary-embolism

Early Intervention Critical: New Data Highlights Benefits of Rapid Thrombectomy in Intermediate-Risk Pulmonary Embolism

Lina Irawan June 23, 2026

The landscape of pulmonary embolism (PE) management is undergoing a significant shift as new clinical data underscores...

A New Frontier in Microsurgery: Tissium Launches COAPTIUM CONNECT Following €60M Capital Injection

Labcorp Launches ColoSense: A New Frontier in Non-Invasive Colorectal Cancer Screening

Revolutionizing Vascular Access: PorTal Access Secures FDA Clearance for FLEXI-PORT System

The Great Pivot: BioNTech’s High-Stakes Bet to Reclaim its Oncology Roots

Masimo Secures FDA Clearance for AI-Powered OIRD Detection to Enhance Hospital Patient Safety

The 340B Standoff: Eli Lilly’s Data Ultimatum Escalates Industry Conflict

The Borderless Pharma Frontier: Architecting Intellectual Property in a Globalized R&D Ecosystem

From Episodes to a Lifetime: The Evolution of Women’s Health Marketing in the Age of AI

FDA in Turmoil: Commissioner Marty Makary Resigns Amid Administrative Pressure and Policy Clashes

Early Intervention Critical: New Data Highlights Benefits of Rapid Thrombectomy in Intermediate-Risk Pulmonary Embolism

You may have missed

The Dismantling of U.S. Global Health: Assessing the Impact of the New Executive Mandates

The Cosmic Pivot: Navigating the Solar Eclipse and the Shift of Mercury and Mars (August 9–15, 2026)

A New Frontier in Cancer Immunotherapy: King’s College London Unveils Groundbreaking IgE Antibody Treatment

Zimmer Biomet Surges: Q2 Financials Spark Market Confidence and Upgraded 2026 Outlook